Patents by Inventor Jyh-Shing Hsu

Jyh-Shing Hsu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11938156
    Abstract: An isolated and purified lactic acid bacteria is provided, which is Lactobacillus paracasei PS23 (PS23) and its applications in delaying aging process, improving immunomodulatory activity, reducing, preventing or treating allergic and inflammation, preventing or treating a chronic disorder and/or (vi) preventing and/or treating a mood disorder or a neurological condition.
    Type: Grant
    Filed: January 4, 2019
    Date of Patent: March 26, 2024
    Assignee: BENED BIOMEDICAL CO., LTD.
    Inventors: Ying-Chieh Tsai, Hui-Yu Huang, Chien-Chen Wu, Jyh-Shing Hsu
  • Patent number: 11564908
    Abstract: Provided is a long-acting method for preventing or treating glucose metabolism disorders that includes administering a beta-lactam compound or a pharmaceutically acceptable salt thereof to a subject in need thereof. The method for preventing or treating glucose metabolism disorders has a long-acting effect that lasts more than two days even after medication has been stopped.
    Type: Grant
    Filed: January 21, 2020
    Date of Patent: January 31, 2023
    Assignee: GLYCOLYSIS BIOMED CO., LTD.
    Inventors: Feng-Ling Lee, Lung-Jr Lin, Jyh-Shing Hsu, Cheng-Hsien Hsu, Yen-Chun Huang, Ya-Chien Huang, Chun-Tsung Lo, Hui-Fang Liao, Yu-Wen Liu, Yu-Chi Kao
  • Patent number: 11419852
    Abstract: Provided is a long-acting method for preventing or treating glucose metabolism disorders that includes administering a beta-lactam compound or a pharmaceutically acceptable salt thereof to a subject in need thereof. The method for preventing or treating glucose metabolism disorders has a long-acting effect that lasts more than two days even after medication has been stopped.
    Type: Grant
    Filed: January 21, 2020
    Date of Patent: August 23, 2022
    Assignee: GLYCOLYSIS BIOMED CO., LTD.
    Inventors: Feng-Ling Lee, Lung-Jr Lin, Jyh-Shing Hsu, Cheng-Hsien Hsu, Yen-Chun Huang, Ya-Chien Huang, Chun-Tsung Lo, Hui-Fang Liao, Yu-Wen Liu, Yu-Chi Kao
  • Publication number: 20210085731
    Abstract: An isolated and purified lactic acid bacteria is provided, which is Lactobacillus paracasei PS23 (PS23) and its applications in delaying aging process, improving immunomodulatory activity, reducing, preventing or treating allergic and inflammation, preventing or treating a chronic disorder and/or (vi) preventing and/or treating a mood disorder or a neurological condition.
    Type: Application
    Filed: January 4, 2019
    Publication date: March 25, 2021
    Applicant: BENED BIOMEDICAL CO., LTD.
    Inventors: Ying-Chieh TSAI, Hui-Yu HUANG, Chien-Chen WU, Jyh-Shing HSU
  • Publication number: 20200230149
    Abstract: Provided is a long-acting method for preventing or treating glucose metabolism disorders that includes administering a beta-lactam compound or a pharmaceutically acceptable salt thereof to a subject in need thereof. The method for preventing or treating glucose metabolism disorders has a long-acting effect that lasts more than two days even after medication has been stopped.
    Type: Application
    Filed: January 21, 2020
    Publication date: July 23, 2020
    Inventors: Feng-Ling Lee, Lung-Jr Lin, Jyh-Shing Hsu, Cheng-Hsien Hsu, Yen-Chun Huang, Ya-Chien Huang, Chun-Tsung Lo, Hui-Fang Liao, Yu-Wen Liu, Yu-Chi Kao
  • Publication number: 20200230105
    Abstract: Provided is a long-acting method for preventing or treating glucose metabolism disorders that includes administering a beta-lactam compound or a pharmaceutically acceptable salt thereof to a subject in need thereof. The method for preventing or treating glucose metabolism disorders has a long-acting effect that lasts more than two days even after medication has been stopped.
    Type: Application
    Filed: January 21, 2020
    Publication date: July 23, 2020
    Inventors: Feng-Ling Lee, Lung-Jr Lin, Jyh-Shing Hsu, Cheng-Hsien Hsu, Yen-Chun Huang, Ya-Chien Huang, Chun-Tsung Lo, Hui-Fang Liao, Yu-Wen Liu, Yu-Chi Kao
  • Publication number: 20040259191
    Abstract: A mutated expandase enzyme having higher activity on penicillin G is provided to produce phenylacetyl-7-aminodeacetoxycephalosporanic acid (7-ADCA), which mutated expandase enzyme has one or more amino acid substitutions selected form M73T, S79E, V275I, L277K, C281Y, G300V, N304K, I305L and I305M.
    Type: Application
    Filed: February 27, 2004
    Publication date: December 23, 2004
    Applicant: Synmax Biochemical Co., Ltd.
    Inventors: Yunn-Bor Yang, Chia-Li Wei, Jyh-Shing Hsu, Ying-Chieh Tsai
  • Publication number: 20030005043
    Abstract: A computer telephony speech system capable of detecting crash and being reset automatically includes a computer telephone speech server unit, and a detecting unit connected to the computer telephony speech server unit. When answering a call, the computer telephony speech server unit issues an active message for being sent to an internal reset module and to the detecting unit via a communication link. If the detecting unit receives no active message in a first predefined time period, a reset message is sent to the reset module for performing a reset operation. If the reset module does not receive any active message or reset message in a second predefined time period, a reset operation is performed automatically. The second predefined time period is larger than the first predefined time period.
    Type: Application
    Filed: September 21, 2001
    Publication date: January 2, 2003
    Applicant: Industrial Technology Research Institute
    Inventor: Jyh-Shing Hsu